HK · Other

SIHUAN PHARMACEUTICAL HOLDINGS GRO (460)

Other

SIHUAN PHARMACEUTICAL HOLDINGS GRO (460) is listed on HK in the Other sector. As of 2026-05-21, reported P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 460

P/E ratio

18.00

Gross profit (TTM)

$0

Net margin

0.0%

SIHUAN PHARMACEUTICAL HOLDINGS GRO (460) — FAQ

What is 460's P/E ratio?

The price-to-earnings (P/E) ratio for SIHUAN PHARMACEUTICAL HOLDINGS GRO (460) is 18.00 (data as of 2026-05-21).

Does SIHUAN PHARMACEUTICAL HOLDINGS GRO pay a dividend?

Dividend yield is not available in the current snapshot for SIHUAN PHARMACEUTICAL HOLDINGS GRO (460). Check the MyAverix Finance app for the latest dividend data.

What sector is SIHUAN PHARMACEUTICAL HOLDINGS GRO in?

SIHUAN PHARMACEUTICAL HOLDINGS GRO (460) is classified in the Other sector.

What exchange is 460 listed on?

460 is listed on HK.

What is SIHUAN PHARMACEUTICAL HOLDINGS GRO's net margin?

SIHUAN PHARMACEUTICAL HOLDINGS GRO (460) reports a net margin of 0.0% (data as of 2026-05-21).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Other companies

Adobe Inc (ADB) AIA GROUP (7A2) Amazon.com Inc (AMZ) AMERICAN EXPRESS (AEC1) Apple Inc (APC) Berkshire Hathaway Inc (BRYN) EXXON MOBIL (XONA) Honeywell International Inc (ALD)